Back

David S Perlin

David S Perlin is affiliated with the Public Health Research Institute.[1]He is a member of the Rutgers New Jersey Medical School.[2]

Perlin is the former executive director of the Rutgers New Jersey Medical School's Public Health Research Institute and former director of the Rutgers Regional Biocontainment Laboratory.[3]He is a highly accomplished biomedical researcher and administrator, and widely recognized as a global leader in antifungal drug resistance, molecular diagnostics and drug discovery.[4]The NIH has continuously funded him for 30 years, and he was most recently awarded a $33.3 million NIH grant to establish a Center of Excellence in Translational Research.[5]According to his biography, he focuses on fungal and bacterial infections, and he is known for his work with drug-resistant fungal infections.[6]Dr. Perlin also serves on advisory and planning boards for several major international conferences, and he is a member of the Steering Committee for Microbiology, Immunology & Infectious Diseases of the New York Academy of Sciences.[7]He has published more than 215 papers and book chapters and has co-authored two books.[8]

Events - Primer's event detection algorithm clusters and summarizes multiple documents describing real-world events.

Mentions - Mentions are snippets of text that map to a person.

Docs - The number of documents that match to a person in Primer's corpus of news articles.

Full tech explainer here.

Create an article for David S Perlin on Wikipedia

Remember to check the sources and follow Wikipedia's guidelines.

Public Health Research Institute

Employer

  • 1

    Event

  • 241

    Mentions

  • 67

    Docs

Recent events

Proper diagnosis of fungal infection is essential - Know why?

New Delhi: As per a recent study, improper diagnosis of fungal infections could force doctors to prescribe more of antibiotics. The study showed that inadequate attention by physicians to fungal infection is the major cause failure of antibacterial treatment. "If we're trying to deliver globally on a comprehensive plan to prevent antimicrobial resistance and we're treating blindly for fungal infections that we don't know are present with antibiotics, then we may inadvertently be creating greater antibiotic resistance," said lead author David Perlin, Rutgers University in New Jersey, US. Fungal infections, often undiagnosed, result in 1.5 million deaths a year, said researchers from the Global Action Fund for Fungal Infections.[910]

2017-01-18

Event Date

References